Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan

Abstract Cryopyrin-associated periodic syndrome (CAPS) is an orphan disease with incidence of about one in 1,000,000 persons. This autoinflammatory disease develops in the neonatal period or early childhood, with various inflammatory symptoms occurring repeatedly throughout the patient's lifeti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Modern rheumatology 2013-05, Vol.23 (3), p.425-429
Hauptverfasser:	Yokota, Shumpei, Nishikomori, Ryuta, Takada, Hidetoshi, Kikuchi, Masako, Nozawa, Tomo, Kanetaka, Taichi, Kizawa, Toshitaka, Miyamae, Takako, Mori, Masaaki, Heike, Toshio, Hara, Toshiro, Imagawa, Tomoyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Canakinumab Child development Cryopyrin-associated periodic syndrome Genetic disorders Human anti-human IL-1β monoclonal antibody Inflammatory diseases Interleukin-1β Monoclonal antibodies Patients Proteins Signal transduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!